Free Trial

Oscar Health (NYSE:OSCR) Sets New 52-Week Low - Should You Sell?

Oscar Health logo with Finance background

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $12.85 and last traded at $12.54, with a volume of 1260755 shares traded. The stock had previously closed at $13.76.

Analysts Set New Price Targets

Several equities research analysts have issued reports on OSCR shares. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group assumed coverage on Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $21.56.

Get Our Latest Analysis on Oscar Health

Oscar Health Price Performance

The company has a fifty day simple moving average of $14.76 and a 200 day simple moving average of $16.74. The stock has a market capitalization of $3.31 billion, a price-to-earnings ratio of -669.42, a P/E/G ratio of 0.50 and a beta of 1.73. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Equities research analysts forecast that Oscar Health, Inc. will post 0.91 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Richard Scott Blackley sold 25,279 shares of the business's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $457,044.32. Following the completion of the transaction, the chief financial officer now owns 881,841 shares in the company, valued at approximately $15,943,685.28. The trade was a 2.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 103,610 shares of company stock worth $1,847,519 in the last quarter. Insiders own 25.11% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Tower Research Capital LLC TRC grew its position in Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after acquiring an additional 4,185 shares in the last quarter. KBC Group NV increased its position in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares during the last quarter. ORG Wealth Partners LLC purchased a new position in shares of Oscar Health during the 4th quarter valued at about $100,000. Alberta Investment Management Corp bought a new stake in Oscar Health in the 4th quarter worth approximately $138,000. Finally, Virtu Financial LLC purchased a new stake in Oscar Health in the fourth quarter worth approximately $140,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Stories

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines